This announcement is a separate document:
国浩律师（杭州）事务所关于浙江华康药业股份有限公司2023年限制性股票激励计划首次授予相关事项之法律意见书
Legal opinion from Guohao Lawyers (Hangzhou) Firm on matters relating to the first grant of the 2023 Restricted Stock Incentive Plan of Zhejiang Huakang Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.